Viking Therapeutics, Inc. (VKTX) has 4 SEC Form 4 insider filings on record in the last 90 days. Most recent filing: Aug. 7, 2026.
| Date | Insider | Value | Shares | Stake | Pre-planned | Links |
|---|---|---|---|---|---|---|
| Aug. 7, 2026 filed Aug. 1, 2026 | Kelly-Gemmell Dorothy Elizabeth Director | $0 | 47,133 | +18% | No | |
|
|
||||||
| July 29, 2026 filed July 28, 2026 | ZANTE GREG Chief Financial Officer | — | +10,450 | +5% | No | |
|
|
||||||
| July 29, 2026 filed July 28, 2026 | Lian Brian President & CEO | — | +73,150 | +3% | No | |
|
|
||||||
| July 29, 2026 filed July 28, 2026 | Mancini Marianna Chief Operating Officer | — | +13,450 | +3% | No | |
|
|
||||||
Form 4 is the filing company officers, directors and 10% shareholders must submit to the SEC within two business days of trading their own company's stock. Open-market purchases generally carry more signal than sales, which are often scheduled in advance. More on how this works.
Real-time Telegram alerts the moment a Form 4 is filed. Filings shown here are delayed by 72 hours.
Start free